Connection Silicon Valley, which helps Canadian startups connect with the Silicon Valley ecosystem, has announced that applications are now open for the Canadian Women’s Network Fall Cohort.

The Centre for Commercializing Regenerative Medicine (CCRM) and the University Health Network (UHN) have opened a new Centre for Cell and Vector Production which will produce clinical-grade cells and viral vectors for Phase 1 and 2 clinical trials. 

iBionics received a $5,000 grant from the Women Founders Fund, which aims to alleviate some of the financial barriers women in the STEM industry face when starting and accessing opportunities for business and professional growth.

Flosonics was named a finalist for 2018 Ontario Centres of Excellence Martin Walmsley Award for Entrepreneurship, which carried a prize of $25,000.

RetiSpec will collaborate with the University of Minnesota to commercialize their technology for early detection of Alzheimer’s disease.

TR Talks is hosted by the University of Toronto's Translational Research Program (TRP) and is intended to provoke discussion and community building. The next talk will be October 30th on the topic of "Pathways to Market: Post clinical trials." 

The Consulate General of Canada in Chicago, in partnership with the Chicago Innovation Mentors (CIM), is offering the opportunity to participate in a comprehensive mentoring program to five Canadian life science and healthcare start-ups.

Through the partnership, Stryker's will offer Synaptive’s BrightMatter™ Plan software, which automatically generates high-fidelity, dynamic, whole-brain tractography. 

ManagingLife's CEO Tahir Janmohamed discussed recent partnerships and plans for the future in an article titled, "Biomedical Zone gives startups place to validate in clinical settings."

The Synapse Life Science Competition is designed to help move innovative life science products and services out of the lab and into the market. The top-ranked teams will deliver a business pitch, competing for up to $60,000 in cash and in-kind prizes.

The 2018 Nobel Prize in Physics was awarded jointly to Canadian Donna Strickland and co-laureate Gérard Mourou, whose research paved the way towards the shortest and most intense laser pulses created by humankind. Dr. Strickland is an associate professor at the University of Waterloo, and is one of three women to receive the Nobel Prize in Physics.

The Centre for Aging + Brain Health Innovation (CABHI), led by Baycrest, has announced support for the development and validation testing of 31 new innovations in aging and brain healthcare, resulting in a total of $1.4 M in support through CABHI’s Spark program.

Vasomune Therapeutics, a leading biotechnology company developing therapeutics targeting vascular dysfunction and inflammation, announced that Douglas A. Hamilton has been appointed President and Chief Executive Officer of the company.

Syng Pharmaceuticals is working with the Impact Centre to develop a new non-invasive diagnostic test for endometriosis, an immunologic condition affecting one in ten women.

The University of Waterloo announced a 4-year, $400,000 partnership with Manulife Financial to support artificial intelligence research in disability claim prediction as well as fraud detection and natural language comprehension in customer service.

Cyclica announced a multi-phase collaboration with Eurofarma to advance drug discovery programs by driving insights into small molecule polypharmacology.

Nanology Labs (OBIO Pre-CAAP 2018) was one of six companies to receive $50,000 from the Ontario Brain Institute's ONtrepreneurs program - Canada’s largest single award focused on neurotechnology.

Therapure Biomanufacturing announced approval for the manufacturing of partner Insmed’s ARIKAYCE® at its Mississauga facility by the U.S. FDA. ARIKAYCE is the first and only treatment approved by the FDA specifically for patients with Mycobacterium avium complex lung disease, a chronic and debilitating condition that can significantly increase patient morbidity and mortality.

The 2018 Nobel Prize in Physiology or Medicine was awarded jointly to James P. Allison and Tasuku Honjo “for their discovery of cancer therapy by inhibition of negative immune regulation.”

HealthTO meetups bring together the Toronto healthcare community to discuss topics related to the future of innovation in health and wellness. On October 10, hear from Jay Couse, CEO and Co-Founder of Spxtrm Health (OBIO Pre-CAAP 2017 Company).